Induced Sputum Cell Counts in Healthy Adults
Overview
Affiliations
Induced sputum cell counts provide a relatively noninvasive method to evaluate the presence, type, and degree of inflammation in the airways of the lungs. Their interpretation requires a knowledge of normal values from a healthy population. The objective was to examine the total and differential cell counts in induced sputum from a sample of healthy adults. A total of 118 healthy nonsmoking adults were studied. None had asthma or airflow obstruction (negative history, FEV(1) >/= 80% predicted, ratio of FEV(1) to vital capacity [FEV(1)/VC] >/= 80%, methacholine PC(20) >/= 16 mg/ml). Forty-six were atopic. Sputum induction produced an adequate sample in 96 subjects [53 males, mean age (range) 36 (18 to 60) yr]. The expectorate was processed within 2 h; sputum was selected, treated with dithiothreitol, filtered, and examined in a hemocytometer for total cell count and viability and on Wright-stained cytospins for a differential cell count. The mean, median (90th percentile) total cell count was 4.1, 2.4 (9.7) x 10(6) cells/g and cell viability was 69.6, 72.0 (89.7)%. The proportions of eosinophils were 0.4, 0.0 (1.1)%, neutrophils 37.5, 36.7 (64.0)%, macrophages 58.8, 60.8 (86.1)%, lymphocytes 1.0, 0.5 (2.6)%, metachromatic cells 0.0, 0.0 (0.04)%, and bronchial epithelial cells 1.6, 0.3 (4.4)%, respectively. Female gender and atopy were associated with a significant elevation of eosinophils; mean difference between male/female was 0.3% (p = 0.043) and between atopic/nonatopic 0.4% (p = 0.024). This study has identified reference values for total and differential cell counts in induced sputum of healthy adults.
Biomarkers of genotoxic damage in pulmonary alveolar macrophages: a review.
DAgostini F, La Maestra S Arch Toxicol. 2024; 99(1):211-224.
PMID: 39453481 DOI: 10.1007/s00204-024-03894-0.
New targets for type 2-low asthma.
Luu Quoc Q, Choi Y, Hur G, Park H Korean J Intern Med. 2024; 39(2):215-227.
PMID: 38317271 PMC: 10918384. DOI: 10.3904/kjim.2023.299.
Sputum induction and its diagnostic applications in inflammatory airway disorders: a review.
Goncalves B, Eze U Front Allergy. 2023; 4:1282782.
PMID: 37901763 PMC: 10600502. DOI: 10.3389/falgy.2023.1282782.
How inhaled corticosteroids target inflammation in COPD.
Lea S, Higham A, Beech A, Singh D Eur Respir Rev. 2023; 32(170).
PMID: 37852657 PMC: 10582931. DOI: 10.1183/16000617.0084-2023.
Development of Adaptive Immunity and Its Role in Lung Remodeling.
Esnault S, Jarjour N Adv Exp Med Biol. 2023; 1426:287-351.
PMID: 37464127 DOI: 10.1007/978-3-031-32259-4_14.